Insight Molecular Diagnostics to Present Kidney Tech
The diagnostics firm will join an investor forum to discuss the commercial potential of its GraftAssure transplant monitoring.
Live Poll
Do you trust the potential of emerging molecular diagnostic technology to improve long-term patient health outcomes?